BioChange Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Crowdfunding
- (Announced)
- Investors
-
2
BioChange General Information
Description
Developer of a tissue regeneration technology designed to stimulate tissue repair and remodeling at the injected site. The company manufactures injectable scaffold, injectable foam and bio-protective shield spray to facilitate the healing and repair of damaged tissues, enabling healthcare professionals to mimic the healthy extra-cellular matrix and trigger the body to repair itself.
Contact Information
Website
www.biochange.lifeCorporate Office
- Hayetzira 13
- Yokneam 2066717
- Israel
Corporate Office
- Hayetzira 13
- Yokneam 2066717
- Israel
BioChange Timeline
BioChange Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Equity Crowdfunding | Announced | Generating Revenue | ||||
| 4. Later Stage VC (Series A) | 01-Dec-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 20-Oct-2023 | Completed | Generating Revenue | |||
| 2. Equity Crowdfunding | 01-Oct-2021 | Completed | Generating Revenue | |||
| 1. Grant | 01-Aug-2017 | $50K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
BioChange Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BioChange Patents
BioChange Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022299473-A1 | Microparticle tissue scaffold compositions, apparatuses, methods of preparation, and uses thereof | Pending | 21-Jun-2021 | ||
| CA-3224921-A1 | Microparticle tissue scaffold compositions, apparatuses, methods of preparation, and uses thereof | Pending | 21-Jun-2021 | ||
| EP-4358988-A2 | Microparticle tissue scaffold compositions, apparatuses, methods of preparation, and uses thereof | Pending | 21-Jun-2021 | ||
| EP-4358988-A4 | Microparticle tissue scaffold compositions, apparatuses, methods of preparation, and uses thereof | Pending | 21-Jun-2021 | ||
| US-20240399024-A1 | Microparticle tissue scaffold compositions, apparatuses, methods of preparation, and uses thereof | Pending | 21-Jun-2021 | A61L27/227 |
BioChange Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BioChange Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Impact Assets | Impact Investing | Minority | ||
| quadraScope Ventures | Venture Capital | Minority |
BioChange FAQs
-
When was BioChange founded?
BioChange was founded in 2017.
-
Where is BioChange headquartered?
BioChange is headquartered in Yokneam, Israel.
-
What is the size of BioChange?
BioChange has 16 total employees.
-
What industry is BioChange in?
BioChange’s primary industry is Other Commercial Products.
-
Is BioChange a private or public company?
BioChange is a Private company.
-
What is BioChange’s current revenue?
The current revenue for BioChange is .
-
How much funding has BioChange raised over time?
BioChange has raised $18M.
-
Who are BioChange’s investors?
Impact Assets and quadraScope Ventures have invested in BioChange.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
